Quantcast

A China Gamma-Butyrolactone Market Report, 2008

July 16, 2008

Research and Markets (http://www.researchandmarkets.com/research/a5bec8/china_gbl_gammab) has announced the addition of the “China GBL (Gamma-butyrolactone) Market Report, 2008″ report to their offering.

GBL (gamma-butyrolactone) is an excellent high boiling solvent and important organic synthesis midbody. It has high solubility and good electrical properties and stability. And it is safe and convenient to use.

GBL is mainly used in the synthesis of ketopyrrolidine series products, like tranylcypromine, and acetyl-GBL. Moreover, GBL is widely used in agriculture, chemicals, polymers and dye and solvents for printing and extracting agents for petrochemicals. GBL can be the raw material for producing spice, medical midbody, rust remover and plant growth regulators.

The demand for GBL is growing continually as the petrochemical industry and other associated industries develop rapidly.

The report is based on data issued by authoritative organizations like the National Bureau of Statistics of China, China Customs and China Petroleum and Chemical Industry Association. It includes in-depth research results and analysis of China’s GBL market.

The 2008 Research and Investment Constant Report on China’s GBL Market is the latest and most detailed GBL report of China. It provides import references for investing and getting to know the latest development trends of the Chinese GBL industry.

This report can be delivered within 5 working days.

Key Topics Covered:

– Brief Introduction to GBL

– GBL Production Techniques and Technique Development

– 2006-2007 GBL Production Status and Producers in China

– GBL Down-stream Application

– GBL Consumption and Demand

– 2006-2007 Statistics and Analysis of GBL Import and Export of China

– 2006-2007 GBL Market Price in China and Price Analysis

– 2002-2008 GBL Projects under Construction and to be Constructed

– List of Charts

For more information visit http://www.researchandmarkets.com/research/a5bec8/china_gbl_gammab.




comments powered by Disqus